Comment on 'Weight loss in heart failure is associated with increased mortality only in non-obese patients without diabetes' by Niedziela et al.

被引：1
|
作者：
Scherbakov, Nadja [1 ,2 ,3 ,4 ]
Doehner, Wolfram [1 ,2 ,3 ,4 ]
机构：
[1] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany
[2] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany
[3] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany
[4] Charite Univ Med Berlin, Ctr Stroke Res Berlin CSB, Berlin, Germany
来源：
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE | 2020年 / 11卷 / 06期
关键词：
CACHEXIA;
D O I：
10.1002/jcsm.12649
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：1867 / 1868
页数：2
相关论文
共 50 条
  • [41] Long-Term Mortality Associated with Use of Carvedilol vs Metoprolol in Heart Failure Patients with and Without Type 2 Diabetes
    Schwartz, Brian
    Pierce, Colin
    Madelaire, Christian
    Schou, Morten
    Kristensen, Soren L.
    Gislason, Gunnar
    Kober, Lars
    Torp-Pedersen, Christian
    Andersson, Charlotte
    CIRCULATION, 2021, 144
  • [42] Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction.
    Liang, Bo
    Gu, Ning
    DIABETES CARE, 2022, 45 (10) : E150 - E150
  • [43] Can Timely Outpatient Visits Reduce Readmissions and Mortality Among Heart Failure Patients?Letter re: Balasubramanian et al.: Outpatient Follow-Up and 30-Day Adverse EventsReddy et al.
    Meghana Reddy
    Logan Martin
    Jameson Kuang
    Journal of General Internal Medicine, 2025, 40 (2) : 493 - 494
  • [44] Comment on: Cohen et al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 2012;35:1420-1428
    Kral, John G.
    DIABETES CARE, 2013, 36 (04) : E58 - E58
  • [45] Comment on: Cohen et al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 2012;35:1420-1428
    Thukunthla, Shwetha
    Belalcazar, L. Maria
    DIABETES CARE, 2013, 36 (06) : E79 - E79
  • [46] Nesiritide, Heart Failure, and Renal Dysfunction: Irrational Exuberance or Throwing the Baby out with the BathwaterEditorial to: “Impact of Nesiritide on Renal Function and Mortality in Patients Suffering from Heart Failure” by Dontas et al.
    Ronald M. Witteles
    Cardiovascular Drugs and Therapy, 2009, 23 : 183 - 186
  • [47] Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction.
    Santulli, Gaetano
    Frullone, Salvatore
    Morgante, Maria
    Macina, Gaetano
    Pansini, Antonella
    Gambardella, Jessica
    Lombardi, Angela
    Mone, Pasquale
    DIABETES CARE, 2022, 45 (10) : E151 - E152
  • [48] THE ROLE OF PLASMA LEVELS INTERLEUKIN-6 ON MORTALITY IN NON-OBESE PATIENTS WITH NEWLY DIAGNOSED HEART FAILURE, DURING 12-MONTHS OF FOLLOW-UP
    Kotrogiannis, I.
    Chrysohoou, C.
    Vasiliadou, C.
    Papadimitriou, L.
    Pounis, G.
    Aggelopoulos, P.
    Barbetseas, J.
    Metallinos, G.
    Pitsavos, C.
    Stefanadis, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 114 - 115
  • [49] Response to Comment on: Cohen et al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 2012;35:1420-1428
    Cummings, David E.
    Cohen, Ricardo V.
    DIABETES CARE, 2013, 36 (04) : E59 - E59
  • [50] Nesiritide, Heart Failure, and Renal Dysfunction: Irrational Exuberance or Throwing the Baby out with the Bathwater Editorial to: "Impact of Nesiritide on Renal Function and Mortality in Patients Suffering from Heart Failure" by Dontas et al.
    Witteles, Ronald M.
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (03) : 183 - 186
12345